1st Patient Dosed in UK Trial of Anti-Cancer Virus TG6002
News
Transgene’s TG6002 has been successfully given to a first person in a Phase 1/2a clinical trial testing it in colorectal cancer patients with inoperable liver metastasis, the company announced. The ... Read more